Capital Research Global Investors 13D/13G Filings for AbbVie Inc. (ABBV)

Capital Research Global Investors 13D and 13G filings for AbbVie Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
3:46 pm
Sale
2021-02-1613GAbbVie Inc.
ABBV
Capital Research Global Investors37,921,062
2.100%
-48,681,631decrease
(-56.21%)
Filing